Letter | Published:

Effect of dimethylnitrosamine on persistence of methylated guanines in rat liver and kidney DNA

Naturevolume 254pages261262 (1975) | Download Citation

Subjects

Abstract

DIMETHYLNITROSAMINE is a potent carcinogen in many species, inducing tumours of the liver, kidney and lung1,2. It is now well established that the carcinogenic activity of this compound is caused by its metabolic transformation within susceptible tissues to a chemically reactive agent which methylates a variety of cellular macromolecules1–3. In spite of the fact that metabolism of dimethylnitrosamine is eight times greater in the liver than in the kidney, thus the alkylation of macromolecules is eight times greater in liver than kidney, a single large dose of dimethylnitrosamine given to the adult rat induces tumours of the kidney but not of the liver1,4. (Liver tumours are produced in the adult rat only if dimethylnitrosamine is given after partial hepatectomy5 or by repeated small doses or prolonged feeding1,2.) Similar experiments with certain nitrosamides have shown that although they penetrate and subsequently react to alkylate cellular components to a similar extent in many tissues, they do not produce an equal incidence of tumours in all these organs1–4. It seems therefore, that different tissues vary quantitatively in their inherent susceptibility to these carcinogens. We report here results which may provide an explanation for this difference and also for the observation that large doses of dimethylnitrosamine are carcinogenic to the kidney while small doses are not.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Magee, P. N., and Barnes, J. M., Adv. Cancer Res., 10, 163–246 (1967).

  2. 2

    International Agency for Research on Cancer, Monograph on the Evaluation of Carcinogenic Risk of Chemicals to Man, 1, 95–144 (W.H.O. Lyons 1972).

  3. 3

    Magee, P. N., Nicoll, J. W., Pegg, A. E., and Swann, P. F., Biochem. Soc. Trans. (in the press).

  4. 4

    Swann, P. F., and Magee, P. N., Biochem. J., 110, 39–47 (1968).

  5. 5

    Craddock, V. M., J. natn. Cancer Inst., 47, 899–907 (1971).

  6. 6

    Lawley, P. D., Brookes, P., Magee, P. N., Craddock, V. M., and Swann, P. F., Biochim. biophys. Acta, 157, 646–648 (1968).

  7. 7

    Lawley, P. D., in Topics in Chemical Carcinogenesis (edit. by Nakahara, W., et al.), 237–256 (Univ. Tokyo Press, Tokyo, 1972).

  8. 8

    O'Connor, P. J., Capps, M. J., and Craig, A. W., Br. J. Cancer, 27, 153–166 (1973).

  9. 9

    Loveless, A., Nature, 223, 206–207 (1969).

  10. 10

    Gerchman, L. L., and Ludlum, D. B., Biochim. biophys. Acta, 308, 310–316 (1973).

  11. 11

    Lawley, P. D., and Shah, S., Chem.-biol. Interactions, 7, 115–120 (1973).

  12. 12

    Goth, R., and Rajewsky, M. F., Proc. natn. Acad. Sci. U.S.A., 71, 639–643 (1974).

  13. 13

    Craddock, V. M., Biochem. J., 111, 497–502 (1969).

  14. 14

    Margison, G. P., Capps, M. J., O'Connor, P. J., and Craig, A. W., Chem.-biol. Interactions, 6, 119–214 (1973).

  15. 15

    Den Engelse, L., Chem.-biol. Interactions, 8, 329–338 (1974).

  16. 16

    Lawley, P. D., and Brookes, P., Biochem. J., 89, 127–138 (1963).

  17. 17

    Lawley, P. D., and Orr, D. J., Chem.-biol. Interactions, 2, 154–157 (1970).

  18. 18

    Kleihues, P., and Margison, G. P., J. natn. Cancer Inst. 53, 1839–1842 (1974).

  19. 19

    Kirtikar, D. M., and Goldthwait, D. A., Proc. natn. Acad. Sci. U.S.A., 71, 2022–2026 (1974).

Download references

Author information

Affiliations

  1. Courtauld Institute of Biochemistry, Middlesex Hospital Medical School, London, W1P 5PR, UK

    • JOHN W. NICOLL
    • , PETER F. SWANN
    •  & ANTHONY E. PEGG

Authors

  1. Search for JOHN W. NICOLL in:

  2. Search for PETER F. SWANN in:

  3. Search for ANTHONY E. PEGG in:

About this article

Publication history

Received

Issue Date

DOI

https://doi.org/10.1038/254261a0

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.